New combo therapy aims to make inoperable liver cancer operable
NCT ID NCT07368023
First seen Jan 30, 2026 · Last updated May 20, 2026 · Updated 16 times
Summary
This study looks back at medical records of 300 people with liver cancer that cannot be removed by surgery. The goal is to see if combining local treatments (like TACE or radiation) with targeted drugs and immunotherapy can shrink the tumors enough to allow surgery. Researchers will compare these patients to others who had surgery right away.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ningbo Medical Centre Lihuili Hospital
Ningbo, Zhejiang, 315000, China
Conditions
Explore the condition pages connected to this study.